National Health (NHI) Fundamental Analysis: Revenue, Earnings & Valuation

6.27 / 10

Outperform

Fundamentally, NHI receives an Outperform rating and a 6.3/10 score. Strengths include strong Net‑income‑to‑Revenue (0.845) and robust YoY operating‑revenue growth (177%). Weak points are modest gross‑profit margin (41.8%) and high income‑tax ratio (21%). Overall solid positioning.

Analysis Checks(5/10)

Gross profit margin (%)

Value41.83

Score1/3

Weight14.62%

1M Return1.34%

Net income-Revenue

Value0.84

Score3/3

Weight65.20%

1M Return4.45%

Quick ratio

Value2.28

Score2/3

Weight6.47%

1M Return0.57%

Non-current liabilities / Total liabilities (%)

Value53.45

Score1/3

Weight2.60%

1M Return0.24%

Income tax / Total profit (%)

Value21.05

Score0/3

Weight-1.87%

1M Return-0.18%

Operating revenue (YoY growth rate %)

Value177.16

Score2/3

Weight2.19%

1M Return0.20%

Cost of sales ratio (%)

Value64.41

Score2/3

Weight7.84%

1M Return0.69%

Asset-MV

Value-0.49

Score1/3

Weight-13.25%

1M Return-1.40%

Current ratio

Value3.94

Score1/3

Weight3.20%

1M Return0.29%

Net profit / Total profit (%)

Value100.00

Score2/3

Weight13.01%

1M Return1.13%

Is NHI fundamentally strong?

NHI scores 6.27/10 on fundamentals and holds a Discounted valuation at present. Backed by its 9.71% ROE, 37.48% net margin, 27.90 P/E ratio, 2.57 P/B ratio, and -3.50% earnings growth, these metrics solidify its Outperform investment rating.